(Unaudited)
| Three Months Ending | ||||||||
| September 30, 2022 | ||||||||
| Low | High | |||||||
| Gross margin | 58.4 | % | 59.0 | % | ||||
| Adjustment to reconcile gross margin to non-GAAP gross margin: | ||||||||
| Stock-based compensation expense | 0.3 | % | 0.3 | % | ||||
| Non-GAAP gross margin | 58.7 | % | 59.3 | % | ||||
RECONCILIATION OF R&D AND SG&A EXPENSES TO NON-GAAP R&D AND SG&A EXPENSES
(Unaudited, in thousands)
| Three Months Ending | ||||||||
| September 30, 2022 | ||||||||
| Low | High | |||||||
| R&D and SG&A expenses | $ | 136,200 | $ | 140,200 | ||||
| Adjustments to reconcile R&D and SG&A expenses to non-GAAP R&D and SG&A expenses: | ||||||||
| Stock-based compensation expense | (41,500 | ) | (43,500 | ) | ||||
| Non-GAAP R&D and SG&A expenses | $ | 94,700 | $ | 96,700 | ||||
